Greedy Insider · Filing

ASPE · New 13D · ORBIMED ADVISORS LLC and affiliates

ORBIMED ADVISORS LLC and affiliates reported a 12.3% stake in Aspen Neuroscience, Inc. (ASPE) in a Schedule 13D filed on Nov 6, 2026, triggered by an event on Nov 2, 2026.

Describes filing structure, not future returns. Not investment advice.

Primary source: SEC EDGAR · Accession 0000947871-26-000996

Open in the live feed

Greedy Insider - Insider Trading Tracker Greedy Insider tracks SEC Form 4 insider trades, congressional STOCK Act disclosures, and Schedule 13D activist filings, and rates each filing with the Greediness Score - a transparent 0–100 measure of structural conviction. The app requires JavaScript. Data is sourced from SEC EDGAR and official congressional disclosure records. For informational purposes only; not investment advice.